Intelligent Solutions for Oral Drug DeliveryTM
Enteris BioPharma is a clinical stage biopharmaceutical company with an innovative internal pipeline of orally delivered therapeutics. Using our advanced oral drug delivery technology (Peptelligence™) , we are reformulating injectable-only molecules into novel oral products that will have significant medical and commercial impact. Enteris BioPharma offers Peptelligence™ to industry partners seeking drug delivery solutions for their preclinical, clinical and marketed products.
Learn more about our oral delivery technology here.
“We are committed to delivering innovative medicines to meet unmet medical needs. Using our patented delivery technology, we are reformulating injectable molecules into novel oral products that will have significant medical and commercial impact.”
Chief Executive Officer
“We are focused on solving challenging formulation issues for our partners using our proprietary, cutting edge, delivery technology. Our combined strengths in formulation development and manufacturing uniquely position us to be an industry leader in overcoming the formulation challenges to deliver peptides and small molecules orally.”
President and Chief Financial Officer
“We are dedicated to providing our partners a turnkey solution that enables them to rapidly evaluate and implement our delivery technology in a robust pharmaceutical development strategy. With our proven capabilities, we are able to deliver a full 3.2.P filing package and Clinical Trial Material to allow partners quick entry into clinical evaluation.”
Paul Shields, Ph.D.
Chief Operating Officer